Hydrogen and health / Research review
Hydrogen and the heart: cardiac arrest and coronary heart disease
The most serious clinical trial of hydrogen concerns people in a coma after cardiac arrest. In the Japanese HYBRID II trial at 15 hospitals, 46% of people breathing oxygen with hydrogen had regained full function after 90 days, against 21% in the oxygen-only group. This is intensive care medicine: 2% hydrogen in the breathing gas, a ventilator, 18 hours.
Covers
Studies
Human studies: 4 studies in the cards below, including 1 randomised.
How hydrogen was given
Inhalation, hydrogen water.
On this page
The heart: key findings from the studies
- HYBRID II (15 hospitals, 73 people): full function in 46% versus 21%, 90-day survival 85% versus 61%.
- From 2016 to 2022, hydrogen inhalation after cardiac arrest was carried out in Japan under the Advanced Medical Care B scheme.
- These are hospital procedures. A generator for home use is not intended for managing emergencies.
Hydrogen, the heart and the brain: why research began with emergencies
When blood returns to tissue that has been starved of it, a wave of reactive oxygen species arises and deepens the damage. That is why Japanese teams began to study hydrogen precisely in emergencies: in heart attack, stroke and after cardiac arrest.
Hydrogen after cardiac arrest: the pilot study and the HYBRID II trial
In the first study in humans, 5 people received 2% hydrogen for 18 hours with no adverse effects attributed to the inhalation1. From December 2016 the procedure was carried out in Japan under the Advanced Medical Care B scheme, which allows new methods to be assessed alongside services covered by insurance2.
In the HYBRID II trial, 73 comatose people were randomly assigned to oxygen with hydrogen or oxygen alone3. Full function was regained by 46% versus 21% (p=0.03), and 85% versus 61% survived (p=0.02).
Hydrogen and coronary heart disease
In a study with hydrogen water in people with unstable angina, fewer symptoms and more favourable lipids were described4.
Hydrogen and the heart: the studies we refer to
Click an entry to see who took part in the study, how hydrogen was given and what the result was.
What the studies say
Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.
1Cardiac arrest, the first pilot study in humans
no control groupn = 5inhalation2016
Cardiac arrest, the first pilot study in humans
- Participants
- 5 comatose people after out-of-hospital cardiac arrest; Tokyo
- Protocol
- 2% H2 added to the breathing gas for 18 hours, alongside controlled body temperature
- Result
- No adverse effects attributed to the inhalation were recorded. 4 of 5 people survived 90 days with a favourable neurological outcome.
- Study context
- Open-label pilot study without a control group. Participants: 5.
Tamura T i wsp.. Feasibility and safety of hydrogen gas inhalation for post-cardiac arrest syndrome: first-in-human pilot study. Circulation Journal 80(8): 1870-1873. 2016. PubMed 27334126 · DOI
2The status of hydrogen inhalation in Japan
reviewinhalation2020
The status of hydrogen inhalation in Japan
- Protocol
- A commentary on the path of hydrogen inhalation into clinical practice
- Result
- The author describes the inclusion of H2 inhalation after cardiac arrest in Japan's Advanced Medical Care B scheme. He states that below 4% hydrogen in the gas there is no risk of ignition.
- Study context
- Editorial.
Ohta S. Will the hydrogen therapy be approved shortly?. Annals of Translational Medicine 8(6): 264. 2020. Source · DOI
3Out-of-hospital cardiac arrest, post-resuscitation care
randomised trialn = 73inhalation2023
Out-of-hospital cardiac arrest, post-resuscitation care
- Participants
- 39 H2 and 34 control; comatose adults after cardiac arrest of cardiac cause; 15 hospitals in Japan
- Protocol
- 2% H2 added to oxygen for 18 hours in mechanically ventilated people; control: oxygen without H2
- Result
- Full function (mRS 0) after 90 days: 46% vs 21% (p=0.03). 90-day survival: 85% vs 61% (p=0.02).
- Study context
- RCT, 15 centres, double-blind. Participants: 73.
Tamura T i wsp.. Efficacy of inhaled hydrogen on neurological outcome following brain ischaemia during post-cardiac arrest care (HYBRID II): a multi-centre, randomised, double-blind, placebo-controlled trial. EClinicalMedicine 58: 101907. 2023. PubMed 36969346 · DOI · Full text
4Unstable angina, supportive treatment
Hydrogen watercontrolled studyn = 402021
Unstable angina, supportive treatment
- Participants
- Hospitalised people
- Protocol
- 1000–1200 ml/day for 3 months, alongside standard medication
- Result
- Fewer angina symptoms and a more favourable fall in total cholesterol, LDL and apoB than with standard treatment plus placebo water.
- Study context
- Placebo-controlled study. Participants: 40.
Si Y i wsp.. Effects of hydrogen as adjuvant treatment for unstable angina. Experimental biology and medicine (Maywood, N.J.) 246(18): 1981-1989. 2021. PubMed 33899541 · DOI · Full text
Educational information, not medical advice. Full database of publications: Hydrogen Studies.
The heart: topics in this area
The heart and hydrogen: frequently asked questions
How was hydrogen given in the cardiology studies?
After cardiac arrest, 2% hydrogen was added to the breathing gas for 18 hours in people on mechanical ventilation. In the study with hydrogen water, participants drank 1000–1200 ml a day for 3 months alongside standard medication.
Is it a medical device?
No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.
Is hydrogen inhalation safe?
In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.